Skip to content

A randomized controlled trial of ear acupuncture for the relief of pain and anxiety associated with hysterosalpingography

A randomized controlled trial of ear acupuncture for the relief of pain and anxiety associated with hysterosalpingography

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077105
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-10-31
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain and anxiety associated with hysterosalpingography

Interventions

treatment group:Ear press needle
control group:Ear comfort press

Sponsors

The First Affiliated Hospital of Tianjin University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Women aged between 20 and 40; 2. It meets the indication of salpingography; 1) Understand whether the fallopian tube is patency and its shape 2) Understand the uterine cavity shape, determine whether there are malformations and types, uterine adhesions, uterine submucous myoma, endometrial polyps and foreign bodies 3) Habitual abortion for unknown reasons, to understand whether the uterine opening is relaxed, and whether the cervix and uterus are deformed 3. The subjects were able to understand and answer the questionnaire independently; 4. The subjects voluntarily participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Unable to cooperate with the researcher due to incapacity or other reasons; 2. Long-term use of antidepressants and sedatives; 3. Patients with a history of severe cardiovascular disease; 4. Patients with eczema, ulcers, chilblain, etc., who should not bury needles in the ear; 5. Patients with abdominal pain before HSG; 6. Because of cervix adhesion or congenital variation, HSG intubation difficulty can not complete the examination, or after multiple operations can not complete the examination; 7. Pregnancy or menstrual period; 8. Postpartum, abortion, and within 6 weeks after curettage; 9. Iodine allergy; 10. Do not agree to sign the study informed consent. Those who met any of the above criteria were not included in the study.

Design outcomes

Primary

MeasureTime frame
Visual pain simulation score;Correlation state-trait anxiety Scale;

Secondary

MeasureTime frame
Adverse reaction rate;

Countries

China

Contacts

Public ContactDou Zhen

The First Affiliated Hospital of Tianjin University of Chinese Medicine

dz-0820@126.com+86 150 2275 4480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026